• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A comparative study of the interaction of Tamiflu and Oseltamivir carboxylate with bovine serum albumin

tetano

Editor, Senior Moderator
J Photochem Photobiol B. 2012 Nov 29;119C:65-70. doi: 10.1016/j.jphotobiol.2012.11.003. [Epub ahead of print]
A comparative study of the interaction of Tamiflu and Oseltamivir carboxylate with bovine serum albumin.
Vishkaee TS, Mohajerani N, Nafisi S.
Source

Department of Chemistry, Islamic Azad University, Central Tehran Branch (IAUCTB), Tehran, Iran.
Abstract

Oseltamivir phosphate (Tamiflu) is a pro-drug that is metabolized to its active form (Oseltamivir carboxylate), after oral administration. OC inhibits influenza A and B neuraminidases in vitro and OP inhibits influenza virus infection and replication in vitro. Serum albumin is the most abundant of the proteins in the circulatory system of a wide variety of organisms and plays an important role in the transport and deposition of many drugs. The aim of this study was to examine the interaction of BSA with Tamiflu and Oseltamivir carboxylate in aqueous solution at physiological conditions, using a constant protein concentration and various drug contents. FTIR, UV-Vis spectroscopic methods were used to determine the drugs binding mode, the binding constant and the effects of drug complexation on protein secondary structure. Structural analysis showed that OP and OC bind BSA with overall binding constants of K(OP-BSA)=1.88 (?0.16)?10(4)M(-1) and K(OC-BSA)=5.7 (?0.09)?10(2)M(-1). Drug complexation alters protein conformation by major reduction of α-helix and random coil and increase of β-sheet and turn structures that indicate a partial protein destabilization. The results suggest that BSA might act as carrier proteins for OP in delivering it to target molecules.

Copyright ? 2012 Elsevier B.V. All rights reserved.

PMID:
23353784
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/23353784
 
Back
Top Bottom